Literature DB >> 12800951

Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey.

O Ozdemir1, K Arda, M Soylu, O Alyan, A D Demir, E Kütük.   

Abstract

A seroepidemiological study was conducted to assess the seroprevalence of hepatitis B surface antigen (HBs Ag) and antibodies to hepatitis C virus (Anti-HCV) in 14,196 patients hospitalized in our cardiology clinics. Threehundred and fifty five (355) patients (2.43%) were found to be positive for HBs Ag, a hundred and sixty six (166) patients (1.09%) were positive for Anti-HCV and ten patients (0.07%) were positive for both. The presence of HBs Ag and Anti-HCV was similar in patients living in rural and urban areas. The presence of risk factors was greater in the patients with Anti-HCV. The prevalences of HBs Ag and Anti-HCV were found to be comparable with those reported in other mediterranean countries in Europe.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12800951     DOI： 10.1023/A:1023338423566

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  7 in total

1.  The scientific challenge of hepatitis C.

Authors:  J Cohen
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

2.  Prevalence of anti-HCV in subjects of various age groups.

Authors:  A Albano; A Pianetti; M R Biffi; F Bruscolini; W Baffone; V Albano; A Salvaggio
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

3.  Prevalence of hepatitis A, B and C in the Flemish population.

Authors:  M Beutels; P Van Damme; W Aelvoet; J Desmyter; F Dondeyne; C Goilav; R Mak; L Muylle; D Pierard; A Stroobant; F Van Loock; P Waumans; R Vranckx
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

4.  Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece.

Authors:  C Lionis; E Frangoulis; M Koulentakis; E Biziagos; E Kouroumalis
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

5.  Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study.

Authors:  R Dal-Ré; L Aguilar; P Coronel
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

Review 6.  Epidemiology of hepatitis A and B.

Authors:  G J Papaevangelou
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

7.  [Prevalence of antibodies to hepatitis A, hepatitis B and hepatitis C viruses in the German population].

Authors:  W Thierfelder; H Meisel; E Schreier; R Dortschy
Journal:  Gesundheitswesen       Date:  1999-12
  7 in total
  1 in total

1.  N-acetyl cysteine therapy in acute viral hepatitis.

Authors:  Huseyin Gunduz; Oguz Karabay; Ali Tamer; Resat Ozaras; Ali Mert; Omer Fehmi Tabak
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.